Loading...
XNASVMD
Market cap312mUSD
Dec 31, Last price  
8.02USD
1D
0.25%
1Q
0.63%
IPO
347.15%
Name

Viemed Healthcare Inc

Chart & Performance

D1W1MN
XNAS:VMD chart
P/E
30.49
P/S
1.71
EPS
0.26
Div Yield, %
0.00%
Shrs. gr., 5y
0.35%
Rev. gr., 5y
22.90%
Revenues
183m
+31.82%
23,289,00034,601,44831,356,00046,928,00065,271,00080,256,000131,309,000117,062,000138,832,000183,008,000
Net income
10m
+64.63%
9,453,0008,927,3561,228,0008,176,00010,177,0008,525,00031,530,0009,126,0006,222,00010,243,000
CFO
45m
+62.94%
7,591,0009,381,4146,414,00012,024,00022,368,00019,087,00035,110,00022,494,00027,748,00045,212,000
Earnings
Mar 04, 2025

Profile

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
URL
https://www.viemed.com/
IPO date
Dec 22, 2017
Employees
974
Domiciled in
US
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
183,008
31.82%
138,832
18.60%
Cost of revenue
166,202
125,009
Unusual Expense (Income)
NOPBT
16,806
13,823
NOPBT Margin
9.18%
9.96%
Operating Taxes
4,148
2,768
Tax Rate
24.68%
20.02%
NOPAT
12,658
11,055
Net income
10,243
64.63%
6,222
-31.82%
Dividends
Dividend yield
Proceeds from repurchase of equity
(594)
(9,439)
BB yield
0.19%
3.14%
Debt
Debt current
2,006
495
Long-term debt
11,568
893
Deferred revenue
Other long-term liabilities
558
889
Net debt
(3,164)
(19,681)
Cash flow
Cash from operating activities
45,212
27,748
CAPEX
(26,093)
(22,898)
Cash from investing activities
(52,113)
(23,976)
Cash from financing activities
2,826
(15,266)
FCF
8,705
4,037
Balance
Cash
12,839
16,914
Long term investments
3,899
4,155
Excess cash
7,588
14,127
Stockholders' equity
98,197
84,969
Invested Capital
117,189
84,550
ROIC
12.55%
13.65%
ROCE
13.47%
14.01%
EV
Common stock shares outstanding
40,379
39,807
Price
7.85
3.84%
7.56
44.83%
Market cap
316,975
5.33%
300,944
41.72%
EV
313,811
281,541
EBITDA
38,668
29,453
EV/EBITDA
8.12
9.56
Interest
424
197
Interest/NOPBT
2.52%
1.43%